Calidi Biotherapeutics Files 8-K on Financials
Ticker: CLDWW · Form: 8-K · Filed: Mar 31, 2025 · CIK: 1855485
| Field | Detail |
|---|---|
| Company | Calidi Biotherapeutics, Inc. (CLDWW) |
| Form Type | 8-K |
| Filed Date | Mar 31, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, corporate-update
TL;DR
Calidi Biotherapeutics dropped an 8-K on 3/31 detailing financials and operations.
AI Summary
Calidi Biotherapeutics, Inc. filed an 8-K on March 31, 2025, reporting on its Results of Operations and Financial Condition, Regulation FD Disclosure, and Financial Statements and Exhibits. The filing details its corporate information, including its incorporation in Delaware and principal executive offices in San Diego, California.
Why It Matters
This 8-K filing provides an update on Calidi Biotherapeutics' financial condition and operational results, which is crucial for investors to assess the company's performance and future prospects.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of financial information and does not indicate any immediate or significant risks.
Key Players & Entities
- Calidi Biotherapeutics, Inc. (company) — Registrant
- March 31, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- San Diego, California (location) — Address of principal executive offices
- First Light Acquisition Group, Inc. (company) — Former company name
FAQ
What specific financial results are being reported in this 8-K?
The filing indicates 'Results of Operations and Financial Condition' are being reported, but the specific details are not provided in this excerpt.
What is the primary purpose of this 8-K filing for Calidi Biotherapeutics?
The primary purpose is to report on its Results of Operations and Financial Condition, provide Regulation FD Disclosure, and file Financial Statements and Exhibits.
When was Calidi Biotherapeutics, Inc. incorporated?
The filing states the company is incorporated in Delaware.
What was the former name of Calidi Biotherapeutics, Inc.?
The former name of the company was First Light Acquisition Group, Inc.
What is the business address and phone number for Calidi Biotherapeutics, Inc.?
The business address is 4475 Executive Drive, Suite 200, San Diego, California 92121, and the phone number is (858) 794-9600.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 31, 2025 regarding Calidi Biotherapeutics, Inc. (CLDWW).